These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22431381)

  • 1. Bioresorbable vascular scaffolds: the shape of things to come?
    Safian RD
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):472-3. PubMed ID: 22431381
    [No Abstract]   [Full Text] [Related]  

  • 2. The future of BRS in bifurcations.
    Kraak RP; Grundeken MJ; Onuma Y; Tu S; Wykrzykowska JJ; Chevalier B; Ormiston J; Serruys PW
    EuroIntervention; 2015; 11 Suppl V():V188-92. PubMed ID: 25983164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of bioresorbable vascular scaffolds: niche or workhorse devices?
    Lahoud R; Ellis S
    Coron Artery Dis; 2017 Sep; 28(6):449-451. PubMed ID: 28644214
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery.
    Gargiulo G; Longo G; Capodanno D; Francaviglia B; Capranzano P; Tamburino C
    JACC Cardiovasc Interv; 2015 May; 8(6):e95-e97. PubMed ID: 25999117
    [No Abstract]   [Full Text] [Related]  

  • 5. Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds.
    Gogas BD; Garcia-Garcia HM; Onuma Y; Muramatsu T; Farooq V; Bourantas CV; Serruys PW
    JACC Cardiovasc Interv; 2013 Mar; 6(3):211-21. PubMed ID: 23517830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First-in-man demonstration of complete bioresorbable vascular scaffold resorption after treatment of in-stent restenosis.
    Moscarella E; Ielasi A; Cortese B; De Angelis MC; Varricchio A
    Coron Artery Dis; 2017 Aug; 28(5):437-439. PubMed ID: 28574901
    [No Abstract]   [Full Text] [Related]  

  • 7. Restenosis in Magmaris Stents Due to Significant Collapse.
    Yang H; Zhang F; Qian J; Chen J; Ge J
    JACC Cardiovasc Interv; 2018 May; 11(10):e77-e78. PubMed ID: 29730376
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioresorbable vascular scaffold implantation for recurrent in-stent restenosis: an option in case of multiple failures?
    Ielasi A; Saino A; Silvestro A; Personeni D; Tespili M
    EuroIntervention; 2014 Jul; 10(3):337. PubMed ID: 24647134
    [No Abstract]   [Full Text] [Related]  

  • 9. Feasibility and efficacy of bioresorbable vascular scaffolds use for the treatment of in-stent restenosis and a bifurcation lesion in a heavily calcified diffusely diseased vessel.
    Naganuma T; Costopoulos C; Latib A; Sato K; Miyazaki T; Colombo A
    JACC Cardiovasc Interv; 2014 May; 7(5):e45-6. PubMed ID: 24746654
    [No Abstract]   [Full Text] [Related]  

  • 10. Bioresorbable Stents: Is This Where We Are Headed?
    Wayangankar SA; Ellis SG
    Prog Cardiovasc Dis; 2015; 58(3):342-55. PubMed ID: 26319497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Very late bioresorbable vascular scaffold thrombosis: a new clinical entity.
    Azzalini L; Al-Hawwas M; L'Allier PL
    EuroIntervention; 2015 May; 11(1):e1-2. PubMed ID: 25982486
    [No Abstract]   [Full Text] [Related]  

  • 12. In-scaffold restenosis in a previous left main bifurcation lesion treated with bioresorbable scaffold v-stenting.
    Miyazaki T; Panoulas VF; Sato K; Kawamoto H; Naganuma T; Latib A; Colombo A
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt A):e7-e10. PubMed ID: 25499306
    [No Abstract]   [Full Text] [Related]  

  • 13. Embolization of Fractured Bioresorbable Scaffold Struts: Insights From 2- and 3-Dimensional Optical Coherence Tomography.
    Capranzano P; Francaviglia B; Capodanno D; Di Salvo ME; Tamburino CI; Santagati FM; Tamburino C
    JACC Cardiovasc Interv; 2016 Feb; 9(4):e37-e38. PubMed ID: 26777323
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioresorbable scaffolds: rationale, current status, challenges, and future.
    Iqbal J; Onuma Y; Ormiston J; Abizaid A; Waksman R; Serruys P
    Eur Heart J; 2014 Mar; 35(12):765-76. PubMed ID: 24366915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Late Restenosis After Bioresorbable Scaffold Implantation Due to Simultaneous External Compression of the Scaffold and Intrascaffold Tissue Growth.
    Tanaka A; Ruparelia N; Kawamoto H; Latib A; Colombo A
    JACC Cardiovasc Interv; 2016 Jan; 9(2):e15-7. PubMed ID: 26723762
    [No Abstract]   [Full Text] [Related]  

  • 16. The year in cardiology 2015: coronary intervention.
    Steg PG; Serruys PW; Abdelghani M; Wijns W
    Eur Heart J; 2016 Jan; 37(4):335-43. PubMed ID: 26726048
    [No Abstract]   [Full Text] [Related]  

  • 17. Bioresorbable Coronary Scaffolds: Deployment Tips and Tricks and the Future of the Technology.
    Costa JR; Abizaid A
    Methodist Debakey Cardiovasc J; 2018; 14(1):42-49. PubMed ID: 29623171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of drug eluting stents.
    Anis RR; Karsch KR
    Heart; 2006 May; 92(5):585-8. PubMed ID: 16216857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioresorbable scaffold technologies.
    Onuma Y; Ormiston J; Serruys PW
    Circ J; 2011; 75(3):509-20. PubMed ID: 21301138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term outcomes following "full-plastic jacket" everolimus-eluting bioresorbable scaffold implantation.
    Kawamoto H; Panoulas VF; Sato K; Miyazaki T; Naganuma T; Sticchi A; Latib A; Colombo A
    Int J Cardiol; 2014 Dec; 177(2):607-9. PubMed ID: 25443250
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.